These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8435989)

  • 1. Is serum anhydroglucitol an alternative to the oral glucose tolerance test for diabetes screening? The Mauritius Noncommunicable Diseases Study Group.
    Robertson DA; Alberti KG; Dowse GK; Zimmet P; Tuomilehto J; Gareeboo H
    Diabet Med; 1993; 10(1):56-60. PubMed ID: 8435989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for diabetes: does measurement of serum fructosamine help?
    Swai AB; Harrison K; Chuwa LM; Makene W; McLarty D; Alberti KG
    Diabet Med; 1988 Oct; 5(7):648-52. PubMed ID: 2975548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 1,5-anhydroglucitol, HbA1c, and fructosamine for detection of diabetes mellitus.
    Yamanouchi T; Akanuma Y; Toyota T; Kuzuya T; Kawai T; Kawazu S; Yoshioka S; Kanazawa Y; Ohta M; Baba S
    Diabetes; 1991 Jan; 40(1):52-7. PubMed ID: 2015974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum 1,5-anhydroglucitol level as a screening tool for diabetes mellitus in a community-based population at high risk of diabetes.
    Wang Y; Yuan Y; Zhang Y; Lei C; Zhou Y; He J; Sun Z
    Acta Diabetol; 2017 May; 54(5):425-431. PubMed ID: 27896445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of hemoglobin-Alc, fructosamine, and 1,5-anhydroglucitol in community screening for diabetes mellitus].
    Nagai M; Sakata K; Yanagawa H; Sueta H; Tanaka T; Shirahama S
    Nihon Koshu Eisei Zasshi; 1993 Mar; 40(3):205-12. PubMed ID: 8518435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum fructosamine as a screening test for diabetes in the elderly: a pilot study.
    Cefalu WT; Ettinger WH; Bell-Farrow AD; Rushing JT
    J Am Geriatr Soc; 1993 Oct; 41(10):1090-4. PubMed ID: 8409155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus.
    Emoto M; Tabata T; Inoue T; Nishizawa Y; Morii H
    Nephron; 1992; 61(2):181-6. PubMed ID: 1630543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fructosamine in diabetes screening of the elderly.
    Croxson SC; Absalom S; Burden AC
    Ann Clin Biochem; 1991 May; 28 ( Pt 3)():279-82. PubMed ID: 1872575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of HbA1 and fructosamine in diagnosis of glucose-tolerance abnormalities.
    Guillausseau PJ; Charles MA; Paolaggi F; Timsit J; Chanson P; Peynet J; Godard V; Eschwege E; Rousselet F; Lubetzki J
    Diabetes Care; 1990 Aug; 13(8):898-900. PubMed ID: 2209329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus.
    Mula-Abed WA; Al-Naemi AH
    Saudi Med J; 2003 May; 24(5):477-84. PubMed ID: 12847621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of diabetes mellitus and an assessment of methods of detection among a community of elderly Chinese in Hong Kong.
    Woo J; Swaminathan R; Cockram C; Pang CP; Mak YT; Au SY; Vallance-Owen J
    Diabetologia; 1987 Nov; 30(11):863-8. PubMed ID: 3446553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of type II diabetes mellitus in population of Krakow].
    Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
    Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Postpartum diabetes screening: value of fructosamine determination].
    Huter O; Brezinka C; Sölder E; Kölle D; Drexel H
    Zentralbl Gynakol; 1992; 114(1):18-24. PubMed ID: 1585740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum 1,5-anhydroglucitol when used with fasting plasma glucose improves the efficiency of diabetes screening in a Chinese population.
    Ying L; He X; Ma X; Shen Y; Su H; Peng J; Wang Y; Bao Y; Zhou J; Jia W
    Sci Rep; 2017 Sep; 7(1):11968. PubMed ID: 28931928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fructosamine compared with a glucose load as a screening test for gestational diabetes.
    Roberts AB; Baker JR; Metcalf P; Mullard C
    Obstet Gynecol; 1990 Nov; 76(5 Pt 1):773-5. PubMed ID: 2216223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of age and obesity on glycated haemoglobin and 1,5-anhydroglucitol in screening for type 2 diabetes mellitus.
    Tsukui S; Kobayashi I
    Diabet Med; 1995 Oct; 12(10):899-903. PubMed ID: 8846681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired glucose tolerance in a middle-aged male urban population: a new approach for identifying high-risk cases.
    Eriksson KF; Lindgärde F
    Diabetologia; 1990 Sep; 33(9):526-31. PubMed ID: 2253828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum 1,5-anhydroglucitol levels slightly increase rather than decrease after a glucose load in subjects with different glucose tolerance status.
    Su H; Ma X; Yin J; Wang Y; He X; Bao Y; Zhou J; Jia W
    Acta Diabetol; 2017 May; 54(5):463-470. PubMed ID: 28210869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased serum 1,5-anhydroglucitol in nondiabetic subjects with a family history of NIDDM.
    Tsukui S; Fukumura Y; Kobayashi I
    Diabetes Care; 1996 Sep; 19(9):940-4. PubMed ID: 8875086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum fructosamine: a screening test for diabetes in pregnancy.
    Roberts AB; Baker JR
    Am J Obstet Gynecol; 1986 May; 154(5):1027-30. PubMed ID: 3706426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.